MedWellAI Free Cash Flow (FCF) History (MWAI)
MedWellAI reported −$850,773 in free cash flow for fiscal 2025, an increase of $3.3M from the previous fiscal year, with a free cash flow margin of −143.04%.
View full MedWellAI company overviewMedWellAI free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-06-30 | −$850,773 | $3.3M | — | −143.04% |
| 2024 | 2024-06-30 | −$4.1M | −$700,732 | — | — |
| 2023 | 2023-06-30 | −$3.4M | −$3.4M | — | −88.74% |
| 2022 | 2022-06-30 | −$18,120 | $4.8M | — | −0.28% |
| 2021 | 2021-06-30 | −$4.9M | −$4.1M | — | −262.45% |
| 2020 | 2020-06-30 | −$794,450 | −$43,963 | — | −174.92% |
| 2019 | 2019-06-30 | −$750,487 | $1.0M | — | −268.85% |
| 2018 | 2018-06-30 | −$1.8M | — | — | −574.38% |
MedWellAI quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2026 | 2026-03-31 | −$7,475 | $239,652 | — | −1.21% |
| Q4 2025 | 2025-06-30 | −$108,803 | $810,463 | — | −64.21% |
| Q3 2025 | 2025-03-31 | −$278,152 | $636,191 | — | −98.87% |
| Q2 2025 | 2024-12-31 | −$216,691 | $1.1M | — | −151.68% |
| Q1 2025 | 2024-09-30 | −$247,127 | $687,160 | — | −21526.74% |
| Q4 2024 | 2024-06-30 | −$919,266 | $274,406 | — | — |
| Q3 2024 | 2024-03-31 | −$914,343 | $126,157 | — | −46.10% |
| Q2 2024 | 2023-12-31 | −$1.4M | −$1.1M | — | −78.95% |
| Q1 2024 | 2023-09-30 | −$934,287 | −$41,324 | — | −88.22% |
| Q4 2023 | 2023-06-30 | −$1.2M | −$1.9M | — | −81.51% |
| Q3 2023 | 2023-03-31 | −$1.0M | $2.1M | — | −70.65% |
| Q2 2023 | 2022-12-31 | −$300,831 | $609,050 | — | −81.24% |
| Q1 2023 | 2022-09-30 | −$892,963 | −$509,832 | — | −160.79% |
| Q3 2022 | 2022-03-31 | $685,233 | $1.1M | — | +47.86% |
| Q4 2021 | 2021-06-30 | −$3.1M | −$3.1M | — | −353.39% |
| Q3 2021 | 2021-03-31 | −$909,881 | −$622,759 | — | −130.58% |
| Q2 2021 | 2020-12-31 | −$383,131 | −$204,767 | — | −210.37% |
| Q1 2021 | 2020-09-30 | −$420,059 | −$123,117 | — | −510.85% |
| Q4 2020 | 2020-06-30 | −$32,022 | $192,182 | — | −39.29% |
| Q3 2020 | 2020-03-31 | −$287,122 | −$158,966 | — | −219.33% |
| Q2 2020 | 2019-12-31 | −$178,364 | $27,390 | — | −132.81% |
| Q1 2020 | 2019-09-30 | −$296,942 | −$104,569 | — | −276.32% |
| Q4 2019 | 2019-06-30 | −$224,204 | $936,995 | — | −751.76% |
| Q3 2019 | 2019-03-31 | −$128,156 | $646,660 | — | −274.99% |
| Q2 2019 | 2018-12-31 | −$205,754 | −$48,962 | — | −235.23% |
| Q1 2019 | 2018-09-30 | −$192,373 | $235,045 | — | −166.93% |
| Q4 2018 | 2018-06-30 | −$1.2M | — | — | — |
| Q3 2018 | 2018-03-31 | −$774,816 | — | — | −563.31% |
| Q2 2018 | 2017-12-31 | −$156,792 | — | — | −149.20% |
| Q1 2018 | 2017-09-30 | −$427,418 | — | — | — |
MedWellAI free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$794,450 to −$850,773, a net decrease of $56,323. MedWellAI's latest reported quarter, Q3 2026, generated −$7,475 in free cash flow, an increase of $239,652 year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review MedWellAI filings at SEC.gov ↗